中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Discovery of HyT-Based Degraders of CDK9-Cyclin T1 Complex

文献类型:期刊论文

作者Lin, Rongkun2; Yang, Jie1; Liu, Ting2; Wang, Mingyu3,4; Ke, Chongrong7; Luo, Cheng2,3,4,5,6; Lin, Jin2; Li, Jiacheng3,4; Lin, Hua1
刊名CHEMISTRY & BIODIVERSITY
出版日期2023-07-13
页码10
ISSN号1612-1872
关键词CDK9 cyclin T1 degrader hydrophobic tag protein degradation
DOI10.1002/cbdv.202300769
通讯作者Lin, Jin(linjinscu@fjmu.edu.cn) ; Li, Jiacheng(201728012342073@simm.ac.cn) ; Lin, Hua(hlin@fjnu.edu.cn)
英文摘要Direct modulation of the non-kinase functions of cyclin and CDK-cyclin complexes poses challenges. We utilize hydrophobic tag (HyT) based small-molecule degraders induced degradation of cyclin T1 and its corresponding kinase partner CDK9. LL-CDK9-12 demonstrated the most potent and selective degradation ability, with DC50 values of 0.362 & mu;M against CDK9 and 0.680 & mu;M against cyclin T1. In prostate cancer cells, LL-CDK9-12 showed enhanced anti-proliferative activity than its parental molecule SNS032 and LL-K9-3, the previous reported CDK9-cyclin T1 degrader. Moreover, LL-CDK9-12 suppressed the downstream signaling of CDK9 and AR efficiently. Altogether, LL-CDK9-12 was an effective dual degrader of CDK9-cyclin T1 and helped study the unknown function of CDK9-cyclin T1. These results suggest that HyT-based degraders could be used as a strategy to induce the degradation of protein complexes, providing insights for the design of protein complexes & PRIME; degraders.
WOS关键词TAGGING-MEDIATED DEGRADATION ; TARGETED PROTEIN-DEGRADATION ; SELECTIVE-INHIBITION ; ANDROGEN RECEPTOR ; CANCER ; CDK9 ; TRANSCRIPTION ; POTENT
资助项目Fujian Provincial Natural Science Foundation[2021J01203] ; National Key Ramp;D Program of China[2022YFC3400500] ; National Key Ramp;D Program of China[2021ZD0203900] ; National Natural Science Foundation of China[91853205] ; National Natural Science Foundation of China[81821005] ; National Natural Science Foundation of China[92253303] ; National Administration of Traditional Chinese Medicine[ZYYCXTD-202004] ; Department of Science and Technology of Guangdong Province ; High-level new Ramp;D institute[2019B090904008] ; High-level Innovative Research Institute[2021B0909050003]
WOS研究方向Biochemistry & Molecular Biology ; Chemistry
语种英语
出版者WILEY-V C H VERLAG GMBH
WOS记录号WOS:001030336400001
源URL[http://119.78.100.183/handle/2S10ELR8/306731]  
专题新药研究国家重点实验室
通讯作者Lin, Jin; Li, Jiacheng; Lin, Hua
作者单位1.Fujian Normal Univ, Coll Life Sci, Biomed Res Ctr South China, Fuzhou 350117, Peoples R China
2.Fujian Med Univ, Sch Pharm, Fuzhou 350122, Peoples R China
3.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
4.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
5.Chinese Acad Sci, Zhongshan Inst Drug Discovery, Shanghai Inst Mat Med, Zhongshan 528437, Peoples R China
6.Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Hangzhou 310024, Peoples R China
7.Fujian Normal Univ, Coll Life Sci, Natl & Local United Engn Res Ctr Ind Microbiol & F, Fuzhou 350117, Fujian, Peoples R China
推荐引用方式
GB/T 7714
Lin, Rongkun,Yang, Jie,Liu, Ting,et al. Discovery of HyT-Based Degraders of CDK9-Cyclin T1 Complex[J]. CHEMISTRY & BIODIVERSITY,2023:10.
APA Lin, Rongkun.,Yang, Jie.,Liu, Ting.,Wang, Mingyu.,Ke, Chongrong.,...&Lin, Hua.(2023).Discovery of HyT-Based Degraders of CDK9-Cyclin T1 Complex.CHEMISTRY & BIODIVERSITY,10.
MLA Lin, Rongkun,et al."Discovery of HyT-Based Degraders of CDK9-Cyclin T1 Complex".CHEMISTRY & BIODIVERSITY (2023):10.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。